New study aims to predict breast cancer subtypes without needles
NCT ID NCT07354490
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will check if standard mammogram and ultrasound images can accurately predict the molecular subtype of breast cancer. Researchers will compare imaging features to lab results from biopsies in 122 women with suspected or confirmed breast cancer. If imaging can reliably identify subtypes like Luminal A or HER2-enriched, it might guide treatment decisions faster and less invasively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify breast cancer subtypes using imaging alone, potentially reducing the need for invasive biopsies.
- What could go wrong
- This is an early observational study with only 122 participants. Imaging predictions may not match lab results, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?